The Global Anti-Infective Agents market was valued at approximately USD 136.9 billion in 2023 and is projected to experience a modest growth rate with a CAGR of 1.2% over the forecast period from 2024 ...

The observed lower mortality with remdesivir plus dexamethasone in patients on IMV/ECMO "further supports the growing ...

UCI researchers have uncovered a striking correlation between internet searches for ADHD medications and actual prescription rates during the COVID-19 pandemic.

Surrogates faced a high risk of pregnancy and postpartum complications. (Annals of Internal Medicine) Antihypertensive ...

A U.S. judge ruled that Regeneron Pharmaceuticals cannot immediately block U.S. sales of a proposed copy of its blockbuster ...

The first, called nirmatrelvir, blocks the activity of an enzyme the COVID-19 virus needs to copy itself, also called repl ...

TriLink BioTechnologies and Alphazyme, both part of Maravai LifeSciences, have collaborated to launch CleanScribetm RNA Polymerase, a novel enzyme that reduces double-stranded RNA (dsRNA) in mRNA ...

Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), announced today the expansion of the newly ...

Foster City, California-based Gilead Sciences, Inc. is recalling one lot of Veklury (remdesivir) for Injection 100 mg/vial for ...

FDA recalls Gilead's COVID drug Veklury due to glass particles as 21 states show "very high" virus levels in wastewater ...

The medical device/technology subsectors lagged on concerns that pent-up demand from COVID-19 could wane in the second half ... approval for its breakthrough gene therapy, Elevidys, but the drug was ...